Myriad Genetics MYGN
NASDAQ MYGN
$4.31 +0.08 (+1.89%)
At close: Sep 30, 2026 · 4:00 PM EDT

Myriad Genetics (MYGN) Short term Debt (2016 - 2025)

Updated

Myriad Genetics (MYGN) recorded Short term Debt of $59.4 million in Q2 2025.

Analysis

Myriad Genetics (MYGN) Short term Debt (2016 - 2025) Analysis & Trends

  • The Q2 2025 figure is the highest quarterly Short term Debt since Q2 2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 HCA Healthcare 93.06 Bn 92.50 Bn -
2 Natera 59.36 Bn 55.04 Bn 485.19 Mn
3 Quest Diagnostics 25.72 Bn 24.15 Bn 1.03 Bn
4 Labcorp Holdings 24.93 Bn 22.69 Bn 1.11 Bn
5 Guardant Health 23.83 Bn 19.89 Bn 219.03 Mn
6 Tenet Healthcare 20.58 Bn 11.72 Bn -
7 Tempus AI 14.35 Bn 11.38 Bn 246.50 Mn
8 Encompass Health 11.99 Bn 12.46 Bn -
9 BrightSpring Health Services 11.21 Bn 9.55 Bn 492.75 Mn
10 Myriad Genetics 412.04 Mn -122.56 Mn 127.00 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2025 59.40 Mn
Jun 30, 2021 104.10 Mn
Sep 30, 2016 199.20 Mn
API Access

Myriad Genetics Short term Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=short-term-debt&ticker=MYGN&period=max&api_key=YOUR_API_KEY